Bicara Therapeutics

📍 Boston, United States🗓 Founded 2020👥 50 employees💰 Last funded Jul 2023
Biotechnology Research🌐 bicara.com
Website LinkedIn
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The companys dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Bicara Therapeutics?
Bicara Therapeutics has 2 investors on record on gritt.io, 2 mid-stage.
When did Bicara Therapeutics last raise funding?
The most recent investment in Bicara Therapeutics recorded on gritt.io was in July 2023.
When was Bicara Therapeutics founded?
Bicara Therapeutics was founded in 2020.
What industry is Bicara Therapeutics in?
Bicara Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bicara Therapeutics based?
Bicara Therapeutics is headquartered in Boston, United States.